News | Breast Imaging | April 02, 2018

Diagnosing Breast Cancer Using Red Light

New design improves sensitivity of optical mammography instruments 1,000-fold

Diagnosing Breast Cancer Using Red Light

Schematic diagram for OM instrument: Seven pulsed lasers sequentially illuminate the compressed breast; transmitted light is detected by the 8-channel SiPM probe and the TDC acquires the signal. Credit: Edoardo Ferocino

April 2, 2018 — Optical mammography (OM), which uses harmless red or infrared light, has been developed for use in conjunction with X-rays for diagnosis or monitoring in cases demanding repeated imaging where high amounts of ionizing radiation should be avoided. At the OSA Biophotonics Congress: Biomedical Optics meeting, held April 3-6 in Hollywood, Fla., researchers from Milan, Italy, will report an advance in instrument development that increases the sensitivity of OM by as much as 1,000-fold.

In 2017, an estimated 252,710 new cases of invasive breast cancer were diagnosed in women and 2,470 cases were diagnosed in men1. Many of these diagnoses are made using X-ray mammography. Although standard and widely used, X-ray imaging for breast cancer suffers from both low sensitivity (50-75 percent) and the use of ionizing radiation that cannot be considered completely safe.

The newly-developed instrument replaces two photomultiplier tubes (PMTs) of existing instruments with an eight-channel probe involving silicon photomultipliers (SiPMs) and a multichannel time-to-digital converter. These changes eliminate a pre-scan step that was required to avoid damage to the PMTs. In addition to increased sensitivity, the new instrument is both more robust and cheaper.

While X-ray mammography is widely used and is still the recommended method for routine screenings, its use is limited by the patient’s age, weight or body mass index, the breast tissue itself, whether or not hormone replacement therapy is being used and other issues. In addition, its accuracy — particularly when used in younger women — has been called into question. Other breast imaging techniques, such as magnetic resonance imaging (MRI) and ultrasound, are sometimes suggested, but neither is an effective replacement for X-ray mammography.

Optical imaging methods, on the other hand, have attracted increasing interest for breast cancer diagnosis since both visible and infrared light are highly sensitive to tissue composition. Tumors are characterized by a high volume of blood due to the increased vascularization that occurs as tumors grow. OM can be used to measure blood volume, oxygenation, lipid, water and collagen content for a suspicious area identified through standard X-ray imaging. Collagen measurements are particularly important since this species is known to be involved in the onset and progression of breast cancer.

One major disadvantage to OM imaging is the poor spatial resolution that has been achieved to date. Breast cancer tumors larger than 1 centimeter are very dangerous and more likely to lead to death, so a successful screening technique must be able to resolve smaller lesions. This remains a problem with OM imaging as a stand-alone technique, but combining OM with other imaging methods shows some promise.

A possible advantage to OM, however, is that only gentle pressure need be applied to the breast tissue, in stark contrast to the standard technique for X-ray imaging. In fact, breast compression tends to reduce blood volume in the tissue, which would interfere with the OM image, so some three-dimensional OM detectors being developed use no compression at all, but rather surround the breast tissue with rings of light sources and detectors.

While poor spatial resolution of OM methods remains a challenge, the method does show promise for use in pre-surgical chemotherapy. As Edoardo Ferocino, Politecnico di Milano, Italy, co-author of the work explained, “This technique is able to provide information on the outcome of chemotherapy just weeks after beginning treatment, or possibly even sooner.” Ferocino’s group is planning clinical studies to explore the use of OM to monitor and predict the outcome of chemotherapy.

The investigators in Milan are working with a larger consortium on a project known as SOLUS, “Smart Optical and Ultrasound Diagnostics of Breast Cancer.” This project is funded by the European Union through the Horizon 2020 Research and Innovation Program and aims to combine optical imaging methods with ultrasound to improve specificity in the diagnosis of breast cancer.

For more information: www.osa.org

[1] American Cancer Society. Breast Cancer Facts & Figures 2017-2018. Retrieved from Cancer.org.

Related Content

Category A

Category A

Feature | Breast Density | April 03, 2020 | By Dayna Williams M.D., Shivani Chaudhry, M.D., and Laurie R. Margolies, M.D.
Breast cancer is the most common cance
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2
News | Mammography | March 25, 2020
March 25, 2020 — The...
The 2020 Society of Breast Imaging/American College of Radiology (SBI/ACR) annual symposium has been cancelled, and the event rescheduled for April 8-11, 2020, in Savannah, Ga. #COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SBI20
News | Society of Breast Imaging (SBI) | March 16, 2020
March 16, 2020 — The 2020 Society of Breast Imaging/American College of Radiology (...
DBT, sometimes called 3-D mammography, emerged in the last decade as a powerful tool for breast cancer screening

Images in a 57-year-old woman noted to have "good prognosis" invasive cancer detected at digital breast tomosynthesis (DBT) screening. (a) Craniocaudal view of the left breast obtained with the two-dimensional digital mammography (DM) portion of the DM/DBT screening study demonstrates a subtle area of distortion in the medial left breast. (b) Single-slice image from the left craniocaudal DBT portion of the screening study shows an area of bridging distortion (circle). (c) Electronically enlarged image of the area of concern seen on the left craniocaudal view in a single DBT slice as shown in b. (d) Targeted US scan demonstrates two small adjacent irregular solid masses. US-guided core biopsy yielded an invasive carcinoma of the tubular subtype that was estrogen receptor positive, progesterone receptor positive, and human epidermal growth factor receptor 2 negative. The results of the sentinel node biopsy were negative. Image courtesy of the Radiological Society of North America

News | Breast Imaging | March 11, 2020
March 11, 2020 — A new study published in the journal ...
SoftVue image stacks of sound speed, as shown for cases ranging across the four Breast Imaging Reporting and Data System (BI-RADS) breast density categories

Example: SoftVue image stacks of sound speed, as shown for cases ranging across the four Breast Imaging Reporting and Data System (BI-RADS) breast density categories ((a), fatty; (b), scattered; (c), heterogeneously dense; (d), extremely dense). Note the quantitative scale indicating that absolute measurements are obtained. Image courtesy of MDPI

News | Breast Imaging | March 10, 2020
March 10, 2020 — ...
The study concludes that a combination of Artificial Intelligence algorithms and the interpretations of radiologists could, in the U.S. alone, result in a half million women not having to undergo unnecessary diagnostic tests every year

Researchers who participated in the DM (digital mammography) DREAM Challenge.

News | Mammography | March 07, 2020
March 7, 2020 — The stu...
Christopher Comstock, M.D., ECOG-ACRIN Cancer Research Group study published in JAMA builds evidence for use of abbreviated MRI in women with dense breasts

Christopher Comstock, M.D., (Memorial Sloan Kettering Cancer Center) is the lead author of a paper in JAMA that reports that abbreviated breast MRI detected significantly more (almost 2 and a half times as many) breast cancers than digital breast tomosynthesis (3-D mammography) in average-risk women with dense breasts. Photo courtesy of Memorial Sloan Kettering Cancer Center

News | Breast Imaging | February 26, 2020
February 26, 2020 — According to a study
Women 75-plus May Not Benefit from Breast Cancer Screening
News | Mammography | February 25, 2020
February 25, 2020 — According to newly published research in an article titled...
Recognized as the “Pulitzer Prize of the business press,” the Jesse H. Neal Award finalists are selected for exhibiting journalistic enterprise, service to the industry and editorial craftsmanship
News | Radiology Business | February 19, 2020
February 19, 2020 — Connectiv, a division of The Software and Information Industry Association (SIIA), has announced